<DOC>
	<DOC>NCT01859377</DOC>
	<brief_summary>The purpose of this study is to evaluate the systemic exposure to ibuprofen after single oromucosal administration of the test product V0498 and single oral administration of a reference product.</brief_summary>
	<brief_title>Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Healthy male subject aged 18 to 45 years (inclusive), 18.5 &lt; or = Body Mass Index &lt; or = 30 kg/mÂ², Nonsmoker for at least 6 months Subject agreed to be registered in the Belgium national register "VIP Check International" for this study participation . Positive serology for Hepatitis B Virus antigens, Hepatitis C Virus or Human Immunodeficiency Virus 1 or 2 antibodies, Organic disorder likely to modify absorption, distribution or elimination of the medication, History of sensitivity to ibuprofen or other NonSteroidal AntiInflammatory Drugs (NSAIDs) or to any of the excipients Subject who has donated blood within the past 3 months, Subject who has forfeited his freedom by administrative or legal award, or who is under guardianship or who has been admitted in a sanitary or social institution, Participation in another clinical trial in the previous month or subject still within the exclusion period of a previous clinical trial or is participating in another clinical trial,</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>